Advisory Board September 3, 2025

FDA last week narrowed the approval for new COVID-19 vaccines to high-risk individuals, leading to concerns about who will be able to access the shots and whether insurers will continue to cover them, in today’s roundup of the news in healthcare politics.

White House names new acting CDC director

On Thursday, the White House named deputy HHS secretary Jim O’Neill as acting CDC director following the ousting of former director Susan Monarez.

Last week, Monarez was fired as CDC director after she refused to resign amid pressure from HHS Secretary Robert F. Kennedy Jr. and other officials to implement vaccine policy changes. Meanwhile, several top CDC officials resigned from the agency, citing lost funding, the political climate, and a broader...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System, HHS, Public Health / COVID
FDA guidance eases wearables oversight. But experts have questions about what’s next.
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter

Share Article